| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1021528967 |
| P356 | DOI | 10.1038/SJ.KI.5002191 |
| P698 | PubMed publication ID | 17457380 |
| P2093 | author name string | E Ritz | |
| F Kronenberg | |||
| I M Heid | |||
| D Fliser | |||
| B Kollerits | |||
| MMKD Study Group | |||
| P2860 | cites work | Predictive value of the adipocyte-derived plasma protein adiponectin for restenosis after elective coronary stenting | Q74156542 |
| Adiponectin and mortality in patients with chronic kidney disease | Q80050959 | ||
| The relationship between inflammatory markers, leptin and adiponectin in chronic hemodialysis patients | Q81050138 | ||
| Adiponectin and future coronary heart disease events among men with type 2 diabetes | Q28213958 | ||
| Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement | Q29619465 | ||
| Adiponectin and adiponectin receptors | Q29620248 | ||
| Hydroxylation and glycosylation of the four conserved lysine residues in the collagenous domain of adiponectin. Potential role in the modulation of its insulin-sensitizing activity | Q31044833 | ||
| Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia | Q33946056 | ||
| Epidemiology of the metabolic syndrome | Q34476504 | ||
| A putative role of hypercholesterolemia in progressive glomerular injury | Q36087000 | ||
| Adiponectin: linking the metabolic syndrome to its cardiovascular consequences. | Q36124903 | ||
| The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes | Q36218262 | ||
| Should we quantify insulin resistance in patients with renal disease? | Q36341789 | ||
| Epidemiology of dialysis patients and heart failure patients | Q36418690 | ||
| Adiponectin acts in the brain to decrease body weight. | Q38342591 | ||
| The metabolic syndrome and chronic kidney disease in U.S. adults | Q38941738 | ||
| Plasma adiponectin levels are associated with insulin resistance, but do not predict future risk of coronary heart disease in women | Q40400158 | ||
| Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications fpr metabolic regulation and bioactivity | Q40681900 | ||
| Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults | Q44041092 | ||
| A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome | Q44043262 | ||
| Predictive performance of renal function equations for patients with chronic kidney disease and normal serum creatinine levels. | Q44077392 | ||
| Serum adiponectin and coronary heart disease risk in older Black and White Americans | Q44123126 | ||
| Renal insulin resistance syndrome, adiponectin and cardiovascular events in patients with kidney disease: the mild and moderate kidney disease study | Q44280677 | ||
| Adiponectin is markedly increased in patients with nephrotic syndrome and is related to metabolic risk factors | Q44402760 | ||
| Plasma adiponectin levels and risk of myocardial infarction in men. | Q44843420 | ||
| Possible impairment of transcardiac utilization of adiponectin in patients with type 2 diabetes | Q45034123 | ||
| Genetic architecture of the APM1 gene and its influence on adiponectin plasma levels and parameters of the metabolic syndrome in 1,727 healthy Caucasians | Q45124500 | ||
| The prospective association between adiponectin and coronary artery disease among individuals with type 1 diabetes. The Pittsburgh Epidemiology of Diabetes Complications Study. | Q45199710 | ||
| Asymmetric dimethylarginine and progression of chronic kidney disease: the mild to moderate kidney disease study | Q46522420 | ||
| Influence of gender, age and renal function on plasma adiponectin level: the Tanno and Sobetsu study | Q46580950 | ||
| Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure | Q46699229 | ||
| Adiponectin is inversely associated with renal function in type 1 diabetic patients | Q46748056 | ||
| Apolipoprotein A-IV predicts progression of chronic kidney disease: the mild to moderate kidney disease study | Q46871136 | ||
| Sex-discordant associations with adiponectin levels and lipid profiles in children. | Q51498967 | ||
| Adiponectin and mortality in patients undergoing coronary angiography. | Q51790599 | ||
| Analysis of 14 Candidate Genes for Diabetic Nephropathy on Chromosome 3q in European Populations: Strongest Evidence for Association With a Variant in the Promoter Region of the Adiponectin Gene | Q57312427 | ||
| Adiponectin and Coronary Heart Disease | Q57416324 | ||
| Adiponectin and Coronary Heart Disease: The Strong Heart Study | Q59921177 | ||
| Relationship between vascular disease and age-associated changes in the human kidney | Q69071858 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | chronic renal insufficiency | Q736715 |
| P304 | page(s) | 1279-1286 | |
| P577 | publication date | 2007-04-25 | |
| P1433 | published in | Kidney International | Q6404823 |
| P1476 | title | Gender-specific association of adiponectin as a predictor of progression of chronic kidney disease: the Mild to Moderate Kidney Disease Study | |
| P478 | volume | 71 |
| Q37270838 | Adipokines protecting CKD. |
| Q64094055 | Adiponectin Receptor gene Polymorphisms are Associated with Kidney Function in Elderly Japanese Populations |
| Q35971216 | Adiponectin action: a combination of endocrine and autocrine/paracrine effects. |
| Q58949119 | Adiponectin and renal disease progression: Another epidemiologic conundrum? |
| Q89006688 | Adiponectin attenuates kidney injury and fibrosis in deoxycorticosterone acetate-salt and angiotensin II-induced CKD mice |
| Q38989644 | Adiponectin gene polymorphisms in Egyptian type 2 diabetes mellitus patients with and without diabetic nephropathy |
| Q53452157 | Adiponectin in children and young adults with focal segmental glomerulosclerosis. |
| Q64916669 | Adiponectin is not associated with renal function decline in community-dwelling elderly adults. |
| Q37664101 | Adiponectin retards the progression of diabetic nephropathy in db/db mice by counteracting angiotensin II. |
| Q33825300 | Adiponectin, cardiovascular disease, chronic kidney disease: emerging data on complex interactions |
| Q81794480 | Adiponectin: good, bad, or just plain ugly? |
| Q45093431 | Association of 276G>T adiponectin gene polymorphism to plasma adiponectin and albuminuria in type 2 diabetic patients |
| Q35213584 | Association of adiponectin and leptin with relative telomere length in seven independent cohorts including 11,448 participants |
| Q37066955 | Association of adiponectin gene polymorphisms with type 2 diabetes in an African American population enriched for nephropathy |
| Q35824902 | Association of relative telomere length with progression of chronic kidney disease in two cohorts: effect modification by smoking and diabetes |
| Q28081407 | Cardiovascular biomarkers in chronic kidney disease: state of current research and clinical applicability |
| Q48576993 | Changes in adiponectin and the risk of sudden death, stroke, myocardial infarction, and mortality in hemodialysis patients |
| Q35014953 | Circulating adipocytokines and chronic kidney disease |
| Q34234199 | Circulating adiponectin and cardiovascular mortality in patients with type 2 diabetes mellitus: evidence of sexual dimorphism |
| Q64967146 | Cisplatin nephrotoxicity as a model of chronic kidney disease. |
| Q35203237 | Elevated serum leptin, adiponectin and leptin to adiponectin ratio is associated with chronic kidney disease in Asian adults |
| Q43236381 | Emerging risk factors and markers of chronic kidney disease progression |
| Q90713927 | High serum adiponectin as a biomarker of renal dysfunction: Results from the KNOW-CKD study |
| Q34730685 | Homoarginine and progression of chronic kidney disease: results from the Mild to Moderate Kidney Disease Study |
| Q37414516 | Hypoadiponectinemia and the presence of metabolic syndrome in patients with chronic kidney disease: results from the KNOW-CKD study. |
| Q53749188 | Long-term study of the association of adipokines and glucose variability with diabetic complications. |
| Q57580560 | Low plasma adiponectin levels predict increased urinary albumin/creatinine ratio in type 2 diabetes patients |
| Q37335044 | Obesity, inflammation, and kidney disease. |
| Q43079874 | Plasma adiponectin concentration and insulin resistance: role of successful kidney transplantation |
| Q64109670 | Prospective Study of Sex-Specific Adiponectin Changes and Incident Metabolic Syndrome: The ARIRANG Study |
| Q41869365 | Proteinuria and its relation to diverse biomarkers and body mass index in chronic hemodialysis. |
| Q35896622 | Relationship between body mass index and proteinuria in hypertensive nephrosclerosis: results from the African American Study of Kidney Disease and Hypertension (AASK) cohort |
| Q37671095 | Relationship between plasma adiponectin level with inflammatory and metabolic markers in patients with chronic kidney disease. |
| Q36652777 | Serum adiponectin levels and mortality after kidney transplantation |
| Q59489228 | Serum adiponectin predicts all-cause mortality and end stage renal disease in patients with type I diabetes and diabetic nephropathy |
| Q35219743 | Serum resistin and glomerular filtration rate in patients with type 2 diabetes |
| Q36531707 | Subattomole detection of adiponectin in urine by ultrasensitive ELISA coupled with thio-NAD cycling |
| Q47273776 | The Adiponectin Paradox for All-Cause and Cardiovascular Mortality. |
| Q92021731 | The association of adiponectin with metabolic syndrome and clinical outcome in patients with non-diabetic chronic kidney disease |
| Q35060772 | The association of adiposity with kidney function decline among HIV-infected adults: findings from the Fat Redistribution and Metabolic Changes in HIV Infection (FRAM) study |
| Q34533678 | The role of serum magnesium and calcium on the association between adiponectin levels and all-cause mortality in end-stage renal disease patients |
| Q34346928 | The use of targeted biomarkers for chronic kidney disease |